Erasca Announces First Patient Dosed in HERKULES-1 Phase 1b Trial Evaluating ERAS-007 and ERAS-601 MAPKlamp Combination in RAS/MAPK Pathway-Altered Solid Tumors
Promising preliminary monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in advanced solid…
Building An AM Quality Data Backbone That Makes AI Credible
Visionstate Announces $750,000 financing to Support International Expansion and Strategic Growth
Local AI Registry Launches First Public Registry of AI Business Recommendations
Agereh Technologies to Attend 2026 ACI-NA Annual Conference & Exhibition in Philadelphia
FlameProxies Launches Residential Proxy Network Across 180 Countries Without Contract Commitments